For how we live.
Every article we have published on Antimicrobial Resistance, newest first.
A narrative review synthesising WHO, UNRWA and Gaza health-ministry field data reports the re-emergence of hepatitis A and poliovirus, over 200,000 diarrhoeal cases, and drug-resistant hospital pathogens.
A Cochrane review of six trials found no benefit for the common cold and significantly more adverse effects in adults. Resistant bacterial infections were linked to 4.71 million deaths in 2021.
In the 240-woman ALTAR trial, methenamine hippurate was non-inferior to standard low-dose antibiotic prophylaxis over a year. Most other non-antibiotic prevention strategies still rest on weak evidence.
A sham-controlled trial found FMT shifted bacterial composition but cleared drug-resistant organisms no better than a saline placebo. A second trial shows what a defined replacement product can and cannot yet prove.
The first national estimate of temperature-attributable food poisoning in Australia. A companion study in Queensland tested whether heat also drives drug resistance in the same bug — and found nothing.
Zoliflodacin is the first antibiotic developed solely for gonorrhoea in decades, and a non-profit holds the rights to register it across most of the world.
New EGASP surveillance data released for World AMR Awareness Week show cefixime resistance up from 1.7% to 11% and ciprofloxacin resistance at 95% across 12 reporting countries.